CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 1 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,942,156 | +31.1% | 6,780,726 | +98.2% | 0.00% | – |
Q4 2022 | $2,244,836 | -23.5% | 3,420,963 | +0.2% | 0.00% | – |
Q3 2022 | $2,936,000 | +110.8% | 3,413,863 | +34.5% | 0.00% | – |
Q2 2022 | $1,393,000 | -52.0% | 2,537,723 | -3.0% | 0.00% | – |
Q1 2022 | $2,903,000 | -35.5% | 2,615,010 | -0.1% | 0.00% | – |
Q4 2021 | $4,502,000 | -44.6% | 2,617,410 | -1.2% | 0.00% | -100.0% |
Q3 2021 | $8,131,000 | -22.1% | 2,648,610 | -1.0% | 0.00% | 0.0% |
Q2 2021 | $10,432,000 | +37.2% | 2,674,811 | -1.9% | 0.00% | 0.0% |
Q1 2021 | $7,606,000 | -8.6% | 2,726,311 | +0.2% | 0.00% | 0.0% |
Q4 2020 | $8,322,000 | -50.0% | 2,719,711 | -0.6% | 0.00% | -50.0% |
Q3 2020 | $16,639,000 | +2.6% | 2,736,711 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $16,218,000 | +123.0% | 2,744,117 | -0.0% | 0.00% | +100.0% |
Q1 2020 | $7,272,000 | +5.6% | 2,744,130 | +8.4% | 0.00% | 0.0% |
Q4 2019 | $6,885,000 | -79.2% | 2,531,478 | -7.5% | 0.00% | -75.0% |
Q3 2019 | $33,170,000 | +5.8% | 2,736,788 | -0.0% | 0.00% | 0.0% |
Q2 2019 | $31,341,000 | – | 2,737,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 552 | $2 | 0.00% |